Ad26.Mos.HIV
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ad26.Mos.HIV, covering 2022-03-11 to 2025-02-03. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults [Phase 1]